ID: ALA307459

Max Phase: Preclinical

Molecular Formula: C20H18Cl2O3

Molecular Weight: 377.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(-c2oc3ccc(Cl)cc3c(=O)c2Cl)c(OCC(C)C)c1

Standard InChI:  InChI=1S/C20H18Cl2O3/c1-11(2)10-24-17-8-12(3)4-6-14(17)20-18(22)19(23)15-9-13(21)5-7-16(15)25-20/h4-9,11H,10H2,1-3H3

Standard InChI Key:  ZGMXVFQVTMUJFQ-UHFFFAOYSA-N

Associated Targets(Human)

Adenosine A3 receptor 15931 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adenosine A1 receptor 6163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A2 receptor 1828 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine receptors; A1 & A3 275 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.27Molecular Weight (Monoisotopic): 376.0633AlogP: 6.11#Rotatable Bonds: 4
Polar Surface Area: 39.44Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.83CX LogD: 5.83
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -0.10

References

1. Karton Y, Jiang JL, Ji XD, Melman N, Olah ME, Stiles GL, Jacobson KA..  (1996)  Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.,  39  (12): [PMID:8691424] [10.1021/jm950923i]

Source